loading
Schlusskurs vom Vortag:
$0.264
Offen:
$0.265
24-Stunden-Volumen:
206.00K
Relative Volume:
0.40
Marktkapitalisierung:
$7.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.07M
KGV:
-0.0464
EPS:
-5.78
Netto-Cashflow:
$-7.34M
1W Leistung:
-13.56%
1M Leistung:
-13.97%
6M Leistung:
+11.06%
1J Leistung:
-76.35%
1-Tages-Spanne:
Value
$0.265
$0.2916
1-Wochen-Bereich:
Value
$0.2616
$0.318
52-Wochen-Spanne:
Value
$0.22
$1.30

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name
Firmenname
Adial Pharmaceuticals Inc
Name
Telefon
434-422-9800
Name
Adresse
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Name
Mitarbeiter
7
Name
Twitter
@AdialPharma
Name
Nächster Verdiensttermin
2024-12-12
Name
Neueste SEC-Einreichungen
Name
ADIL's Discussions on Twitter

Vergleichen Sie ADIL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ADIL
Adial Pharmaceuticals Inc
0.2681 7.04M 0 -6.07M -7.34M -5.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
448.96 115.43B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
748.64 78.44B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
872.09 52.42B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
391.82 51.68B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
202.91 42.80B 447.02M -1.18B -906.14M -6.1812

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-14 Eingeleitet Rodman & Renshaw Buy
2018-10-30 Eingeleitet Maxim Group Buy
2018-10-11 Eingeleitet Dawson James Buy

Adial Pharmaceuticals Inc Aktie (ADIL) Neueste Nachrichten

pulisher
Dec 13, 2025

Volume Recap: Why Adial Pharmaceuticals Inc stock could be next big winner2025 Momentum Check & Consistent Return Strategy Ideas - moha.gov.vn

Dec 13, 2025
pulisher
Dec 13, 2025

Litchfield Hills Research Weighs in on ADIL FY2025 Earnings - Defense World

Dec 13, 2025
pulisher
Dec 11, 2025

Adial Pharmaceuticals Secures $2.86M Through Warrant Agreement - MSN

Dec 11, 2025
pulisher
Dec 06, 2025

Adial Pharmaceuticals, Inc. (ADIL) AI-Powered Stock Analysis - Meyka

Dec 06, 2025
pulisher
Dec 05, 2025

How Adial Pharmaceuticals Inc. stock benefits from strong dollarMarket Performance Report & Weekly Return Optimization Plans - Newser

Dec 05, 2025
pulisher
Dec 03, 2025

Can Adial Pharmaceuticals Inc. stock attract ESG capital inflowsPortfolio Return Summary & Low Risk Investment Opportunities - Newser

Dec 03, 2025
pulisher
Nov 28, 2025

Whale Trades: Can Adial Pharmaceuticals Inc. stock continue upward trendPortfolio Update Summary & Low Risk Growth Stock Ideas - moha.gov.vn

Nov 28, 2025
pulisher
Nov 26, 2025

Are Smart Investors Making the Right Decision? Adial Pharmaceuticals Inc (ADIL) - Setenews

Nov 26, 2025
pulisher
Nov 26, 2025

Adial Pharmaceuticals raises $2.86 million through warrant exercise By Investing.com - Investing.com Nigeria

Nov 26, 2025
pulisher
Nov 26, 2025

Adial Pharmaceuticals (ADIL) Announces Warrant Inducement Agreem - GuruFocus

Nov 26, 2025
pulisher
Nov 26, 2025

Adial Pharmaceuticals raises $2.86 million through warrant exercise - Investing.com

Nov 26, 2025
pulisher
Nov 26, 2025

Adial Pharmaceuticals Enters Warrant Inducement Agreement for $2.86 Million Capital Raise - Quiver Quantitative

Nov 26, 2025
pulisher
Nov 26, 2025

Adial Pharmaceuticals (NASDAQ: ADIL) enters $2.86M inducement at $0.31 exercise price - Stock Titan

Nov 26, 2025
pulisher
Nov 26, 2025

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for Approximately $2.86 Million in Gross Proceeds - The Manila Times

Nov 26, 2025
pulisher
Nov 22, 2025

Is Adial Pharmaceuticals Inc a good long term investmentMoving Average Crossovers & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in

Nov 22, 2025
pulisher
Nov 21, 2025

Why Adial Pharmaceuticals Inc. stock could rally in 20252025 Year in Review & Expert Verified Movement Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Adial Pharmaceuticals Inc. stock deliver strong dividend growthJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Why Adial Pharmaceuticals Inc. stock could benefit from AI revolutionProfit Target & Safe Capital Growth Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What high frequency data says about Adial Pharmaceuticals Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Detecting price anomalies in Adial Pharmaceuticals Inc. with AIJuly 2025 Outlook & Short-Term High Return Strategies - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Is this a good reentry point in Adial Pharmaceuticals Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Adial Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - MarketScreener

Nov 17, 2025
pulisher
Nov 16, 2025

Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Forecasting Adial Pharmaceuticals Inc. price range with options data2025 Momentum Check & Weekly Return Optimization Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can Adial Pharmaceuticals Inc. stock withstand economic slowdownJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Will Adial Pharmaceuticals Inc. stock continue upward momentumStock Surge & Reliable Price Breakout Signals - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Adial Pharmaceuticals' Loss Shrinks As Hopes For AD04 Grow - Finimize

Nov 15, 2025
pulisher
Nov 14, 2025

Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025Portfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Adial Pharmaceuticals (ADIL) Advances Towards FDA Approval with AD04 - GuruFocus

Nov 14, 2025
pulisher
Nov 14, 2025

Adial Pharmaceuticals Q3 net loss beats expectations on lower R&D expenses - MarketScreener

Nov 14, 2025

Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$38.54
price up icon 0.12%
$97.59
price up icon 0.76%
$31.68
price up icon 1.02%
$92.87
price up icon 0.67%
biotechnology ONC
$305.25
price down icon 0.24%
$201.21
price up icon 0.22%
Kapitalisierung:     |  Volumen (24h):